NCT01600352View on ClinicalTrials.gov

Specific Autoantibody Testing in Patients With Interstitial Lung Disease

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2017

Conditions
Interstitial Lung Disease
Trial Locations (1)

169608

Singapore General Hospital, Singapore

All Listed Sponsors
lead

Singapore General Hospital

OTHER

NCT01600352 - Specific Autoantibody Testing in Patients With Interstitial Lung Disease | Biotech Hunter | Biotech Hunter